SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin built on the Runes protocol, generating excitement for its fair launch and perceived potential to mirror $DOGE.X's success. The community emphasizes its strong connection to the Bitcoin blockchain, arguing it offers enhanced security and utility compared to meme coins on other networks. Discussions also highlight the growing #DOGArmy and anticipation for broader exchange listings.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as the community discusses potential catalysts including a spot ETF and the Market Clarity Act. Many are expressing bullish sentiment and accumulating HBAR, while also highlighting its real-world use cases and institutional partnerships. Mentions of Hedera's meme coin $GIB.X are also contributing to the increased attention.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as the U.S. Department of Commerce has selected it to verify and distribute economic data onchain, marking a significant step in the adoption of decentralized infrastructure. The community sees this as a major validation of Pyth's role as a trusted data source and anticipates further expansion of its data offerings. Discussions revolve around potential price targets and the impact of institutional adoption on the broader crypto market.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending due to discussions around high short interest, the cost to borrow shares, and potential for a short squeeze following its recent reverse stock split. Community members are debating the impact of the split on the stock's price and future, with some expressing concern over potential dilution and others pointing to the company's technology and Saudi backing as reasons for optimism. Recent news highlights include the CEO's rebuttal of third-party sales data and the closing of a $300 million investment from Uber.

Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTLido, Elyxyb, and Gloperba. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.

Scilex Holding Company

SCLX is trending as investors discuss the potential impact of the upcoming Semnur merger vote and the possibility of a dividend payout. The community is actively debating the company's strategic moves, particularly in relation to short sellers, and anticipating a potential short squeeze. Discussions also include Scilex's relationship with Sorrento and the potential for a combined buyout.

Samsara, Inc. develops internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA.

Samsara Inc - Ordinary Shares - Class A

Samsara Inc

Samsara ($IOT) is trending following a positive earnings report, driving discussions around the company's growth and future potential. Community members are analyzing analyst ratings and price target adjustments, while also weighing in on the impact of new partnerships and product innovations. Some traders are monitoring insider selling, and the overall impact of recent institutional activity.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending due to an upgrade from UBS to a buy rating, citing long-term growth drivers and potential upside. Community discussions revolve around the stock's disconnect from other semi plays like AMD and NVDA, with some viewing it as an underrated buy-and-hold opportunity. Despite some analyst caution around 2026, the broader sentiment remains optimistic, especially regarding the company's unique position in lithography.

ViaSat, Inc. engages in providing communications technologies and services. It operates through the Communication Services and Defense and Advanced Technologies business segments. The Communication Services business segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets. The Defense and Advanced Technologies business segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging the company’s technical competencies in encryption, cyber security, tactical gateways, modems, and waveforms. The company was founded by Mark D. Dankberg and Mark J. Miller on May 1, 1986 and is headquartered in Carlsbad, CA.

Viasat, Inc.

Viasat ($VSAT) is trending due to recent news, potentially fueled by an upcoming earnings call. Community members are actively debating the stock's prospects and valuation, with some pointing to substantial government contracts and potential value unlocking opportunities while others express concerns about debt and historical performance. Discussions also involve comparisons to competitors like AST SpaceMobile and Starlink, alongside speculation on potential short squeezes.

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.

Cidara Therapeutics Inc

Cidara Therapeutics is trending as investors discuss the potential of its universal flu protection, CD388, following positive Phase 2b trial results. Community talking points include speculation around upcoming milestones like FDA decisions and BARDA funding, as well as potential buyout scenarios given the strong data and market opportunity. Some traders are also eyeing technical indicators, noting accumulation patterns and potential for a breakout, while others discuss the impact of a potential share offering.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC is trending after announcing positive Phase 3 trial results for its breast cancer therapy, showing significant reduction in disease progression. The community is buzzing with speculation about FDA approval and potential M&A activity, driving the stock to new highs. Traders are weighing the potential for continued gains against concerns of a possible offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Tenon Medical, Inc. surged more than 280% on Tuesday, marking their best day ever, with the nano-cap medical device firm's retail following&nbsp;on Stocktwits surging the most among healthcare stocks after a key regulatory approval.During after-hours trading on Monday, Tenon said that the U.S. Food and Drug Administration had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion."With this approval, the Catamaran is now indicated to treat the SI [sacroiliac] joint as either a stand-alone treatment or to augment a spinal fusion," the company said in a statement.Tenon's Catamaran system is designed as a minimally invasive solution for stabilizing the joint where the lower spine and pelvic bone meet. It uses a single titanium implant to secure the joint by passing through key bone structures.&nbsp;On Stocktwits, Tenon gained 25% more followers from a day ago, as sentiment turned even more 'extremely bullish' while message volume soared by 813%.One user said if the stock breaks the $5 level again, it "will go to $7+ fast. Shorts will have to cover."<stembedurl>https://stocktwits.com/BullsEye2000/message/609170603</stembedurl>However, Tenon shares fell more than 5% in Tuesday's extended trading after the company announced a $1.5 million registered direct offering to a healthcare-focused institutional investor.&nbsp;Under the agreement, Tenon will issue 733,500 shares at $2 each and an equal number of warrants exercisable at the same price.&nbsp;The company expects to close the offering on Wednesday, and the proceeds will be used for working capital and general corporate purposes.However, several optimistic retail watchers were still not rankled. One user said, "Everyone's panicking over the offering, but it was a direct offering so it got them secured cash to move forward without diluting the base rapidly."<stembedurl>https://stocktwits.com/FLCaptain/message/609231053</stembedurl>Tenon's stock has gained a whopping 93% so far this year. The sole analyst covering it on Wall Street rates it a 'strong buy,' according to Koyfin.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Tenon Medical Stock Rockets Nearly 4x, Leads Retail Follower Surge In Healthcare: What's Driving The Hype?

The medical device company said that the FDA had cleared its Catamaran SI Joint Fusion System for expanded use in augmenting thoracolumbar fusion.

Equity

Shares of surgical solutions firm Tenon Medical, Inc (TNON) shot up over 145% on Friday after the company announced the pricing of its public offering of shares and warrants in order to meet a Nasdaq minimum float requirement.The firm had earlier received a letter from Nasdaq stating that it did not meet the “minimum 500,000 publicly held shares requirement.”&nbsp;The compliance issue followed Tenon Medical common stock’s 1-for-8 reverse split which reduced the firm’s outstanding common stock from a little over 4.08 million shares to 510,221 shares outstanding on a post-reverse split basis. Only 490,364 of such shares qualified as publicly held shares for purposes of the minimum float requirement, the firm said in an SEC filing.Nasdaq had provided time till October 24, 2024 for the firm to come up with a plan to regain the compliance. Tenon, however, stated that it expects to regain compliance with the minimum float requirement in September itself.On Friday, the company announced the pricing of its "reasonable best efforts" public offering with a single health-care focused institutional investor for the purchase and sale of up to 1,222,850 shares of common stock and warrants to purchase an equal number of shares at a combined offering price of $3.68 per share.Tenon expects to receive aggregate gross proceeds of approximately $4.5 million, assuming no exercise of the warrants. The firm said that the warrants will have an exercise price of $3.55 per share and will be exercisable immediately. They will expire five years from the issuance date, Tenon said.The offering is expected to close on Sept. 16, 2024, with Tenon intending to use the net proceeds for commercial activity, working capital and general corporate purposes.In early September, the firm entered into a securities purchase agreement with certain investors to offer a total of 86,454 Series B preferred stock and warrants to purchase 16,214 shares of common stock at an exercise price equal to $4.2756 per share for an aggregate offering price of $550,000.Tenon Medical’s shares have gained more than 87% over the last month, with the firm attracting investor eyeballs in the wake of the compliance developments.&nbsp;As a result, Stocktwits message volume shot up a whopping 64,900% during the same period as investors continued to discuss the fate of the stock.Some investors, however, are advising to maintain caution.<stembedurl>https://stocktwits.com/Spacerobot/message/585993209</stembedurl>Also See: <a href="https://stocktwits.com/news/markets/equity/united-airlines-to-offer-free-inflight-wifi-using-spacexs-starlink/c7zC6s5R5e">United Airlines To Offer Free Inflight Wi-Fi From SpaceX’s Starlink: Retail Sentiment Gets A Boost</a>

Nasdaq had provided time till October 24, 2024 for Tenon Medical to come up with a plan to regain the compliance.

Tenon Stock Skyrockets 145% After Public Offering To Meet Nasdaq Rules: Retail Chatter Goes Through The Roof

The firm had earlier received a letter from Nasdaq stating that it did not meet the “minimum 500,000 publicly held shares requirement.”

Tenon Medical (TNON) Stock Is Up 180%: What's Going On?

Tenon Medical shares are trading higher by 180% during Friday's session. The company announced the pricing of a $4.5 million public offering of 1.22 million shares and warrants.
read more...

Tenon Medical, Inc. Enhances Board with New Appointment

The latest announcement is out from Tenon Medical, Inc. (TNON). Tenon Medical, Inc. has bolstered its Board of Directors with the appointment of Kr...

Tenon Medical's Partnership Perils: Navigating Uncharted Waters in Search of Commercial Success

Tenon Medical, Inc. (TNON) has disclosed a new risk, in the Corporate Activity and Growth category. Tenon Medical, Inc. faces significant business...

Tenon(R) Medical Appoints Kristine Jacques to its Board of Directors

Experienced Medical Devices Industry Executive Joins Tenon's Board of DirectorsLOS GATOS, CA / ACCESSWIRE / March 28, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ('Tenon' or the 'Company'), a company...

Tenon Medical announces results from post-market study of Catamaran system

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Tenon(R) Medical Announces Positive Fusion Results in First Patients Reaching 12-Month Follow Up in an IRB Approved, Multi-Centered, Post-Market Study Utilizing the Catamaran(R) SI Joint Fusion System

Preliminary SI Joint Fusion Results Based on Independent Radiologist Review Indicate Robust Fusion at 12-Months Post-ProcedureInitial Patient Results Demonstrate Marked Improvements in Pain Scores...

Q4 2023 Tenon Medical Inc Earnings Call Transcript

Recap: Tenon Medical Q4 Earnings

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.

Current Price	$1.18
Prev Close	$1.15
Open	$1.13
Dividend Yield	0.00%
50-Day Moving Average	$1.20
Beta	1.05
Avg. Volume	13.12M
PE Ratio	-0.20

52-Week High	$15.79
52-Week Low	$0.85
Market Capitalization	$10.48M
EPS (Annual)	-$11.26
Price to Book	3.03
Revenue Per Employee	$121,370.37
Enterprise Value/EBITDA	N/A

TNON
Tenon Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TNON News

TNON Tenon Medical Inc